Laboratoire Servier News and Activities

Laboratoire Servier has a direct presence in 5 countries.

Laboratoire Servier has 6 subsidiaries including Biogaran, Day One Biopharmaceuticals and Servier Laboratory and Industrial.

They are in:

• Pharmaceuticals71%
• Biotechnology29%

Acquisition, funding and merger involving Laboratoire Servier.

• Laboratoire Servier has announced the acquisition of Edgewise Therapeutics  (posted on June 4 2026).
• Laboratoire Servier has acquired Day One Biopharmaceuticals (posted on April 24 2026).
• Laboratoire Servier has announced the acquisition of Day One Biopharmaceuticals  (posted on March 9 2026).

View the org chart displaying its 103 main executives

Most searched biographies at Laboratoire Servier

• Olivier Laureau, Chief Executive Officer
• Catherine Mazzacco, Director
• Jean-Christophe Tellier, Director

Popular executive movements at Laboratoire Servier

• Eric Fohlen-Weill, Director of External Communication, has left the company  (posted on October 17 2025).

Create your alert
to follow the executive moves at Laboratoire Servier.

Laboratoire Servier has 1,913 competitors including Sanofi (France), Moderna (United States (USA)) and Eli Lilly (United States (USA)).

Popular M&A news in Pharmaceuticals

• Eli Lilly has acquired Centessa Pharmaceuticals (posted on June 24 2026).
• Polpharma has acquired Biofarm (posted on June 24 2026).
• AbbVie has announced the acquisition of Apogee Therapeutics  (posted on June 23 2026).

Popular contacts in Pharmaceuticals

• Joaquin Duato - Chief Executive Officer and Chairman of the Board at Johnson & Johnson
• Tracey Franklin - Chief People and Digital Technology Officer at Moderna
• Richard Saynor - Chief Executive Officer at Sandoz

Learn more about the Pharmaceuticals industry

Press releases by Laboratoire Servier

• Seedpods Day: Honoring Servier’s junior researchers
• More complex, more open: innovation as an archipelago
• Servier joins the United Nations Global Compact
• Servier and n-Lorem Foundation join forces to advance research in rare neurodevelopmental disorders
• Acquisition of Edgewise Therapeutics’ Muscular Dystrophy Business
• Cytospire Therapeutics: First investment for Servier Ventures
• #BecauseISaySo: How to keep blood pressure under control!
• Servier completes the acquisition of Day One Biopharmaceuticals
• Servier x L’ADN: The patient as a partner, a new figure in care
• Discover Mécénat Servier Charity Fund annual report
• View more press releases Close

Social media about Laboratoire Servier

• Laboratoire Servier on Wikipedia, Google News & Yahoo Finance
• Laboratoire Servier on LinkedIn, X (Twitter) & YouTube